🆕A newly published piece in @natureportfolio.nature.com examines the NeoSep1 trial expansion led by GARDP
Aiming to enrol 3,000+ newborns across Africa and Asia, the trial will generate evidence that clinicians can use immediately, leading to better outcomes for newborns.
🔗 bit.ly/4vbZ4LY
nature.com
NeoSep1 trial widens to find better sepsis treatment for newborns
Researchers test tailored antibiotic combinations for babies in African hospitals to boost survival.